CHEBI:176975 - KP1339

ChEBI IDCHEBI:176975
ChEBI NameKP1339
Stars
DefinitionA ruthenium coordination entity that is the sodium salt of tetrachloro[bis(1H-indazole)]ruthenate(III). It is a anticancer drug in clinical development for the treatment of solid tumours.
Last Modified3 August 2021
DownloadsMolfile
FormulaC14H12Cl4N4Ru.Na
Net Charge0
Average Mass502.150
Monoisotopic Mass500.87573
SMILES[Cl][Ru-3]([Cl])([Cl])([Cl])([n+]1cc2ccccc2n1)[n+]1cc2ccccc2n1.[Na+]
InChIInChI=1S/2C7H6N2.4ClH.Na.Ru/c2*1-2-4-7-6(3-1)5-8-9-7;;;;;;/h2*1-5H,(H,8,9);4*1H;;/q;;;;;;+1;+3/p-4
InChIKeyWVVOCRYXBTVDRN-UHFFFAOYSA-J
Roles Classification
Biological Role:
apoptosis inducer  Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
Application:
antineoplastic agent  A substance that inhibits or prevents the proliferation of neoplasms.
ChEBI Ontology
Outgoing Relation(s)
KP1339 (CHEBI:176975) has role antineoplastic agent (CHEBI:35610)
KP1339 (CHEBI:176975) has role apoptosis inducer (CHEBI:68495)
KP1339 (CHEBI:176975) is a ruthenium coordination entity (CHEBI:35733)
IUPAC Name 
sodium tetrachloro[bis(1H-indazole-κN2)]ruthenate(1−)
Synonyms  Source
BOLD-100SUBMITTER
IT-139SUBMITTER
NKP-1339SUBMITTER
sodium trans-[tetrachloridobis(1H-indazole)ruthenate(III)]ChEBI
KP-1339ChEBI
Registry NumbersSources
CAS:197723-00-5ChemIDplus
Citations